CN115154377A - Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition - Google Patents
Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition Download PDFInfo
- Publication number
- CN115154377A CN115154377A CN202210939145.2A CN202210939145A CN115154377A CN 115154377 A CN115154377 A CN 115154377A CN 202210939145 A CN202210939145 A CN 202210939145A CN 115154377 A CN115154377 A CN 115154377A
- Authority
- CN
- China
- Prior art keywords
- skin care
- essence
- irritation
- bud extract
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 74
- 230000007794 irritation Effects 0.000 title claims abstract description 58
- 241000218645 Cedrus Species 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 239000013566 allergen Substances 0.000 claims abstract description 37
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 18
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 17
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 claims description 16
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 16
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 16
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 16
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 claims description 13
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 9
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 9
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 claims description 9
- 229930007744 linalool Natural products 0.000 claims description 9
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims description 8
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 8
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims description 8
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 8
- LIPHCKNQPJXUQF-KAMYIIQDSA-N 2-benzylidene-1-heptanol Chemical compound CCCCC\C(CO)=C\C1=CC=CC=C1 LIPHCKNQPJXUQF-KAMYIIQDSA-N 0.000 claims description 8
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 claims description 8
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 8
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 8
- 239000005770 Eugenol Substances 0.000 claims description 8
- 239000005792 Geraniol Substances 0.000 claims description 8
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 8
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 8
- 241000219492 Quercus Species 0.000 claims description 8
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 claims description 8
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 claims description 8
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 claims description 8
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 claims description 8
- 229960002903 benzyl benzoate Drugs 0.000 claims description 8
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 claims description 8
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 8
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims description 8
- 229940117916 cinnamic aldehyde Drugs 0.000 claims description 8
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 claims description 8
- 229940043350 citral Drugs 0.000 claims description 8
- 235000000484 citronellol Nutrition 0.000 claims description 8
- 229960002217 eugenol Drugs 0.000 claims description 8
- 229940043259 farnesol Drugs 0.000 claims description 8
- 229930002886 farnesol Natural products 0.000 claims description 8
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 8
- 229940113087 geraniol Drugs 0.000 claims description 8
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 8
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 7
- -1 myrcene ketone Chemical class 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 claims description 6
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 claims description 6
- FRLZQXRXIKQFNS-UHFFFAOYSA-N Methyl 2-octynoate Chemical compound CCCCCC#CC(=O)OC FRLZQXRXIKQFNS-UHFFFAOYSA-N 0.000 claims description 6
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 6
- 229940043234 carbomer-940 Drugs 0.000 claims description 6
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 claims description 6
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 claims description 6
- 235000001510 limonene Nutrition 0.000 claims description 6
- 229940087305 limonene Drugs 0.000 claims description 6
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 claims description 6
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 5
- QCRPTFXFDLBLAI-UHFFFAOYSA-N 2-benzyl-2-methylheptanal Chemical compound C(CCC)CC(C=O)(C)CC1=CC=CC=C1 QCRPTFXFDLBLAI-UHFFFAOYSA-N 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- ASWXQKTUJIFQPQ-UHFFFAOYSA-N 2-hydroxy-1-(4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)CCCC1(C=O)CCC=CC1O ASWXQKTUJIFQPQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 claims 1
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Natural products CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 1
- 239000003205 fragrance Substances 0.000 abstract description 15
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 238000012827 research and development Methods 0.000 abstract description 3
- 230000002633 protecting effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 102
- 230000000694 effects Effects 0.000 description 19
- 102000004889 Interleukin-6 Human genes 0.000 description 10
- 108090001005 Interleukin-6 Proteins 0.000 description 10
- 229940100601 interleukin-6 Drugs 0.000 description 10
- 206010040880 Skin irritation Diseases 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 240000005286 Cryptomeria japonica var. sinensis Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 2
- 230000002009 allergenic effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000922 anti-bactericidal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000008799 immune stress Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of infant skin care products, and discloses application of a cedar bud extract in reducing essence irritation of the infant skin care products and a cedar bud extract skin care composition. The cedar bud extract is applied to reducing the irritation of essence of the infant skin care product, can solve the problem of skin intolerance of infants and children caused by the essence allergen of the infant Tong Hufu, and has obvious technical progress and economic value in the research and development of the infant skin care product; can be widely applied to the components listed as the essence allergens and exert the efficacy of the essence allergens in infant products. The skin care composition can play an effective role in moisturizing and protecting the skin of infants, can meet the fragrance of specific requirements, and simultaneously avoids irritation possibly caused by adding essence components.
Description
Technical Field
The invention relates to the technical field of infant skin care products, in particular to application of a cedar bud extract in reducing the irritation of essence of an infant skin care product and a cedar bud extract skin care composition.
Background
The skin is the first line of defense of the human body and has a very important barrier function. For infants, the skin structure development is not complete, and the epidermis, the dermis structure and the skin appendages have obvious difference compared with adults; such as: the literature reports that the thicknesses of the horny layer and the epidermis of the skin of the infant are both obviously lower than that of an adult, the thickness of the horny layer is 30 percent thinner than that of the adult, and the thickness of the epidermis is 20 percent thinner; the premature infant has thinner epidermis; therefore, the barrier function of infants is not mature, the skin sensitivity is much higher than that of adults, and the infants are easily influenced by the change of external environment.
In the prior art, in order to prevent adverse effects on the skin of infants caused by dry weather and other environments, skin care of infants is generally required to be carried out by using infant skin care products. However, as a common allergen in skin care products, essence in infant skin care products is easy to cause immune stress reaction of children, and the skin of infants is red and swollen, pruritus and eczema. Meanwhile, the essence is used as an important sensory index of the skin care product, has the functions of covering bad smell and endowing users with better use experience, plays an important role in most infant skin care products, and is an indispensable part of various skin care products.
Therefore, how to reduce the irritation of the essence in the infant cosmetics while keeping the effect of the essence has very important technical significance and industrial prospect. However, in the prior art, in the field of research and development of infant skin care products, research aiming at reducing the irritation of essence is lacked, and an effective and reliable infant skin care product formula system for reducing the irritation of essence is not formed. The infant skin care products in the prior art cannot meet the requirements of nonirritant and aroma and sensory requirements of the formula at the same time, and the products cannot meet the higher requirements of market consumers. Therefore, there is a need in the art for a skin care product component or an application and formulation system thereof that can reduce the irritation of perfume to solve the above technical problems in the prior art.
Disclosure of Invention
The invention aims to overcome at least one defect of the prior art, provides the application of the cedar bud extract in reducing the irritation of the essence of the infant skin care product, and is used for solving the problem that the essence of the infant skin care product in the prior art easily causes adverse reaction of the skin of the infant.
In addition, the invention aims to overcome at least one of the defects in the prior art, and provides the cedar bud extract skin care composition which has the effects of moisturizing and lubricating, is friendly to the skin of infants, has specific fragrance, and avoids the adverse effect of the corresponding component of the fragrance on the skin of the infants.
Actually, the technical scheme adopted by the invention is to provide an application method of the cedar bud extract in reducing the essence irritation of the infant skin care products, and the cedar bud extract is added into the infant skin care products. In more than one embodiment of the invention, the effect of the cedar bud extract on reducing the irritation of the essence allergen in the infant skin care product is proved, and similarly, the cedar bud extract can also play a role in reducing the irritation of the essence when being added into other types of infant skin care products containing the essence allergen, so that the safety of applying the essence to sensitive skin of infants is guaranteed while the beneficial effects of the essence are utilized. And for the essence which can bring specific fragrance and cannot be widely used due to the fact that the components contain the essence allergen, the irritation defect of the essence can be overcome through the cedar bud extract, so that the cedar bud extract can be widely applied to various skin care compositions and skin care products, and the corresponding skin care compositions and skin care products have specific fragrance and are nonirritant.
Further, the essence contains essence allergens including amyl cinnamic aldehyde, amyl cinnamic alcohol, anisic alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, butylbenzene methyl propionaldehyde, cinnamic aldehyde, cinnamic alcohol, citral, citronellol, coumarin, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, hydroxyisohexyl-3-cyclohexene carboxaldehyde, isoeugenol, alpha-isomethyl ionone, limonene, linalool, methyl 2-octynoate, oak moss extract and/or moss extract.
The invention also aims to provide the application of the cedar bud extract in preparing products for reducing the irritation of the essence allergen. Besides being directly applied to skin care products containing essence, the cedar bud extract can also be directly applied to products with the effect of reducing the irritation of essence allergen based on the effect of the cedar bud extract on reducing the irritation of the essence to the skin.
Further, the essence sensitizer comprises amyl cinnamic aldehyde, amyl cinnamic alcohol, anisyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, butylbenzene methyl propionaldehyde, cinnamic aldehyde, cinnamyl alcohol, citral, citronellol, coumarin, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, hydroxyisohexyl-3-cyclohexene aldehyde, iso-eugenol, alpha-iso-methyl ionone, limonene, linalool, methyl 2-octynoate, oak moss extract and/or moss extract.
The invention also aims to provide a product for reducing the irritation of the essence allergen, which comprises the component of the cedar bud extract. The product can reduce the irritation effect caused by essence allergen by the contained cedar bud extract. The product can be used as a single medicine or cosmetic, and when the essence allergen causes irritation, the product can be applied to the corresponding skin surface to reduce the irritation of the essence allergen. The product can also be used as a raw material component and is compounded with other skin care compositions to form a safe and non-irritant skin care product.
Further, the essence sensitizer comprises amyl cinnamic aldehyde, amyl cinnamic alcohol, anisyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, butylbenzene methyl propionaldehyde, cinnamic aldehyde, cinnamyl alcohol, citral, citronellol, coumarin, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, hydroxyisohexyl-3-cyclohexene aldehyde, iso-eugenol, alpha-iso-methyl ionone, limonene, linalool, methyl 2-octynoate, oak moss extract and/or moss extract.
The invention also aims to provide a skin care composition of the cedar bud extract suitable for infants, which comprises the following components in parts by mass:
1.5-4.5 parts of hexadecanol;
4-6 parts of caprylic/capric triglyceride;
monoglyceride 0.6-1.3;
lecithin 0.2-0.8;
0.5-1.5 parts of carbomer 940;
0.5 to 1.5 portions of triethanolamine;
1-5 parts of a cedar bud extract;
and the number of the first and second groups, 0.0001 to 0.001 portion of amyl cinnamic aldehyde, 0.0001 to 0.001 portion of amyl cinnamic alcohol, 0.0001 to 0.001 portion of anisyl alcohol, 0.0001 to 0.001 portion of benzyl benzoate, 0.0001 to 0.001 portion of benzyl cinnamate, 0.0001 to 0.001 portion of benzyl salicylate, 0.0001 to 0.001 portion of butylbenzyl methyl propionaldehyde, 0.0001 to 0.001 portion of cinnamic aldehyde, 0.0001 to 0.001 portion of cinnamyl alcohol, 0.0001 to 0.001 portion of citral, 0.0001 to 0.001 portion of citronellol, 0.0001 to 0.001 portion of coumarin, 0.0001 to 0.001 portion of eugenol, 0.0001 to 0.001 portion of farnesol, 0.0001 to 0.001 portion of geraniol, 0.0001 to 0.001 portion of hexyl cinnamic aldehyde, 0.0001 to 0.001 portion of hydroxycitronellaldehyde, 0.001 to 0.001 portion of isohexyl cinnamyl alcohol, 0.001 to 0.001 portion of linalool, 0.001 to 0.0001 to 0.001 portion of isoquercus bengal, 0.001 to 0.0001 portion of methyl octinone extract, 0.0001 to 0.001 portion of quercus alucil and 0.0001 to 0.001 portion of methyl octinorin;
deionized water to make up 100 parts.
In the skin care composition provided by the application, the hexadecanol, the caprylic/capric triglyceride can play a role of a softening agent, so that the skin texture is smooth and soft; has certain water retention function; and has no irritation and high safety. Moreover, the caprylic/capric triglyceride can improve the extensibility of the skin care composition, provide lubrication and soften the skin; the caprylic/capric triglyceride also has the function of filtering ultraviolet light, so the skin care composition added with the caprylic/capric triglyceride can also realize the skin protection of infants under the ultraviolet light. The monoglyceride has the effects of emulsification, lubrication and the like, and the addition of the monoglyceride is beneficial to uniform dispersion of all components in the skin care composition, so that the quality of the whole composition is improved. Further, lecithin is added to the skin care composition to ensure the regeneration capability of skin cells, enhance the moisturizing effect and provide an antioxidant effect. Carbomer 940 (namely carbomer 940) is also added into the skin care composition, so that the skin protection effect is enhanced, the anti-inflammatory and bactericidal effects are achieved, and the skin irritation possibly brought by allergen is further reduced; further, through neutralization of triethanolamine and carbomer 940, a stable high molecular structure is favorably formed, and the moisturizing effect is obviously improved.
More importantly, the skin care composition provided by the application can be applied to the components listed as the essence allergens, so that the skin care composition has corresponding fragrance, and the infant skin care product with the requirement on the fragrance is met; meanwhile, the condition that the used essence components cannot cause allergy and the like is ensured through the cedar bud extract, and the irritation of the essence allergen in the skin care composition is reduced, so that the skin care composition with specific fragrance, safety and no irritation is formed.
In more than one embodiment of the invention, experiments of the cryptomeria fortunei bud extract for reducing the irritation of the essence allergen are carried out by combining the 26 essence allergens, and the results effectively prove that: for the skin care composition containing the above 26 allergenic essence components, the addition of cedar bud extract can reduce the irritation thereof while retaining the effects of other components, including moisturizing the skin. Moreover, the cedar bud extract can promote the regeneration of skin tissues and further enhance the skin protection effect in the moisturizing microenvironment provided by other components.
In one embodiment of the invention, the skin care composition adopting the formula system has the characteristics of no irritation and high safety; meets the requirement of specific aroma and can play an effective role in moisturizing the skin.
Further, the content of the cedar bud extract in the composition is 3% by mass. In one embodiment of the invention, the content of the cedar bud extract in the skin care composition is 3 mass%, which can significantly reduce the irritation caused by the essence allergen in the composition; under the proportion, the irritation is obviously reduced, and excessive cedar bud extract can be avoided, so that the cost can be effectively controlled.
Further, the composition comprises the following components in parts by mass:
3 parts of hexadecanol and octadecanol;
5 parts of caprylic/capric triglyceride;
1 part of monoglyceride;
0.5 part of lecithin;
1 part of carbomer 940;
1 part of triethanolamine;
3 parts of a cedar bud extract;
and, amyl cinnamic aldehyde 0.001 parts, amyl cinnamic alcohol 0.001 parts, anisyl alcohol 0.001 parts, benzyl benzoate 0.001 parts, benzyl cinnamate 0.001 parts, benzyl salicylate 0.001 parts, butylbenzyl methylpropionaldehyde 0.001 parts, cinnamic aldehyde 0.001 parts, cinnamic alcohol 0.001 parts, citral 0.001 parts, citronellol 0.001 parts, coumarin 0.001 parts, eugenol 0.001 parts, farnesol 0.001 parts, geraniol 0.001 parts, hexyl cinnamic aldehyde 0.001 parts, hydroxycitronellal 0.001 parts, hydroxyisohexyl-3-cyclohexenecarbaldehyde 0.001 parts, isoeugenol 0.001 parts, alpha-isomethyl ionone 0.001 parts, limonene 0.001 parts, linalool 0.001 parts, methyl 2-octynoate 0.001 parts, oak moss extract 0.001 parts, and moss extract 0.001 parts;
deionized water to make up 100 parts.
<xnotran> , , , , , , , , , , , , , , , , , , , -3- , , α - , , , 2- , , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% -3- , 1wt% , 1wt% α - , 1wt% , 1wt% , 1wt%2- , 1wt% , 1wt% . </xnotran>
In more than one embodiment of the invention, the adopted essence allergen is the essence allergen with the mass percentage concentration. The skin care composition retains the fragrance of the component, has remarkably reduced irritation under the action of cedar bud extract, and is suitable for infant skin.
Still another object of the present invention is to provide an infant skin care product comprising the cedar bud extract skin care composition. On the basis of the skin care composition, other auxiliary materials can be added to prepare other types of infant skin care products. And the skin care composition already comprises the essence component and the cryptomeria fortunei bud extract for reducing the irritation of the essence component, so that the skin care product with more effects is prepared on the basis of the skin care composition, the essence is not required to be additionally added, the specific fragrance of the related essence component is kept, the safety is guaranteed, and the skin care composition is suitable for the sensitive skin of infants.
Further, the infant skin care product comprises lotion, cream, oil and cream.
Compared with the prior art, the invention has the beneficial effects that: the cedar bud extract is used for reducing the irritation of the essence allergen to the skin, improving the use safety and being suitable for the skin of infants. In more than one embodiment of the invention, the cedar bud extract can obviously reduce the expression level of interleukin 6 caused by 26 allergens in the essence, and reduce the degree of skin inflammation, thereby reducing the irritation caused by the essence. The cedar bud extract balances the beneficial effects of the essence components and the sensitization problem of the essence components, so that the skin care product has the effects of the specific essence components, has higher safety and is basically free of irritation. Solves the problem of intolerance of skin of infants caused by the essence allergen of the infant Tong Hufu, and has obvious technical progress and economic value in the research and development of skin care products for infants. Moreover, the application also provides a skin care composition, which can play an effective moisturizing and protecting effect on the skin of an infant, overcomes the adverse effect of 26 essence allergens in the prior art, has corresponding fragrance, meets the requirements on the related fragrance in actual use, and avoids the irritation possibly caused by the fragrance corresponding to the essence components.
Detailed Description
It should be noted that the following detailed description is exemplary and is intended to provide further explanation of the disclosure. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments according to the present application. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, and it should be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof, unless the context clearly indicates otherwise.
The present invention will now be further described with reference to specific examples, which are provided for the purpose of illustration only and are not to be construed as limiting the invention. The test samples and test procedures used in the following examples include the following (generally, according to the conventional conditions or according to the conditions recommended by the reagent company if the specific conditions of the experiment are not specified in the examples; and reagents, consumables and the like used in the following examples are commercially available unless otherwise specified).
Example 1
In this example, the extract was obtained by the bud of Cryptomeria fortunei (available from Jiafa lion, france)
Renew) and proves that the cedar bud extract has the obvious effect of reducing the irritation of the essence in the formula of the infant skin care product.
First, the present inventors determined 26 flavor-sensitive ingredients, as shown in table 1.
TABLE 1 fragrance perfume potentially containing 26 allergenic components listed in the International fragrance Association (IFRA)
Then, on the basis, the inventor utilizes the components to carry out experimental study on the irritation of the essence allergen and the experimental study on the effect of the cedar bud extract on reducing the irritation of the essence.
Specifically, the skin experiment is performed using the 3D skin model in this embodiment. The 3D skin model has a multilayer structure, and the displayed function is similar to an in vivo mechanism, so that the response of a human body to stimulation can be predicted on a cellular and molecular level; through the 3D skin model, the efficacy of the product can be confirmed according to the dynamics of biological response, the influence of the product on the homeostasis on the molecular level and the dynamic change of genome response can be monitored, and the parameters which can not be quantified in vivo can be realized in vitro by means of the 3D skin model. In this embodiment, by designing the 3D skin model of the infant, the model is made to be highly close to the natural skin of the infant in structure, form, tissue environment and physiological characteristics, and the physiology and reactivity of the skin of the infant are realized. This skin model is also an ideal model for studying the interaction between the epidermis and the dermis. This example uses this skin model for experiments.
The primary response of the skin of infants to allergens includes inflammation, which represents a defense response of the body to stimuli, manifested by redness, swelling, heat, pain, dysfunction, and the like. The intensity of the inflammatory response actually represents the irritation of the allergen to the skin. Meanwhile, interleukin 6 (IL-6) is an important member of a cytokine network and can be quantified as an inflammatory response marker. An increase in interleukin 6, indicating the presence of inflammation; the degree of increase is closely related to the inflammatory response, with a more pronounced increase in interleukin 6 indicating a more severe inflammation. Therefore, the degree of the skin irritation of the allergen to the infant can be represented by the content of interleukin 6. This example uses the interleukin 6 content for the characterization of the irritability.
Preparation of a test sample: respectively diluting the 26 allergens to 1 mass percent by using olive oil; comparison products: 100% pure olive oil; taking the sample preparation of amyl cinnamaldehyde from Bellca Biotech, guangzhou as an example, amyl cinnamaldehyde was diluted to 1% by mass with olive oil.
Then, in this example, the test sample or the control was applied to the 3D skin model pretreated with or without cedar bud extract, and the interleukin 6 content was measured at a specific time interval. The results are shown in Table 2.
Table 2 comparison of interleukin 6 contents corresponding to 26 kinds of essence allergens and 100% purity olive oil in pretreated 3D skin models of cedar bud extracts of different concentrations;
as can be seen from Table 2, the cedar bud extract can significantly reduce the expression level of interleukin 6 caused by 26 allergens in the essence, reduce the degree of skin inflammation, and reduce the irritation caused by the essence. Moreover, the cost and the efficacy are combined, and 3 percent of the cedar bud extract is the most suitable proportion in the infant Tong Hufu product.
In order to further verify the effect of reducing the irritation of essence by the cedar bud in the skin care products for babies and children, a composition formula containing the cedar bud extract is provided, and a control test is designed; regulations allow the maximum concentration of a single essence allergen in the infant Tong Hufu product to be 0.001%, and experiments are carried out at the maximum concentration in the example; the skin care composition containing essence and cedar bud extract is obtained. Meanwhile, the effect of the cedar bud extracts in different proportions on reducing the skin irritation is tested according to a skin irritation test method in the technical Specification for cosmetic safety.
The test samples and controls are shown in Table 3 below, including sample A, B, C, D.
Table 3:
detecting according to a test method and a judgment standard of technical Specification for cosmetic safety; specifically, the skin was scored according to the following table 4 in combination with the performance of the sample applied to the skin, and graded according to the scoring results and the skin irritation intensity shown in table 5.
TABLE 4 skin irritation response score
Table 5 skin irritation intensity grading
| Integral mean value | Strength of |
| 0—＜0.5 | Has no irritation |
| 0.5—＜2.0 | Light irritation |
| 2.0—＜6.0 | Middle irritation |
| 6.0—＜8.0 | Strong irritation |
The skin irritation test results for the above samples are shown in table 6 below:
table 6:
| sample (I) | Results of irritation test |
| Sample A | Strong irritation |
| Sample B | Light irritation |
| Sample C | Has no irritation |
| Sample D | Has no irritation |
From the above results, it can be seen that the cedar bud extract can significantly reduce the irritation of the formulation and significantly reduce the irritation of the skin care composition under the maximum amount of added essence allergen allowed by the regulations. In particular, formulations containing 3% or more of the cedar bud extract reduce the irritation of the formulation from a strong irritation level to a non-irritating level, compared to formulations without the cedar bud extract.
It should be understood that the above-mentioned embodiments of the present invention are only examples for clearly illustrating the technical solutions of the present invention, and are not intended to limit the specific embodiments of the present invention. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention claims should be included in the protection scope of the present invention claims.
Claims (10)
1. An application method of a cedar bud extract in reducing the irritation of essence of an infant skin care product is characterized in that the cedar bud extract is added into the infant skin care product.
2. Application of cedar bud extract in preparing product for reducing irritation of essence allergen is provided.
3. Use according to claim 2, wherein the essence sensitizer comprises amyl cinnamic aldehyde, amyl cinnamic alcohol, anisyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, butylbenzyl methylpropionaldehyde, cinnamic aldehyde, cinnamic alcohol, citral, citronellol, coumarin, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, hydroxyisohexyl-3-cyclohexene carbaldehyde, isoeugenol, alpha-isomethyl ionone, limonene, linalool, methyl 2-octynoate, oak moss extract and/or moss extract.
4. A product for reducing the irritation of an essence allergen comprises a component of a cedar bud extract.
5. A product according to claim 4, wherein the essence sensitizer comprises amyl cinnamic aldehyde, amyl cinnamic alcohol, anisyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, butylbenzyl methylpropionaldehyde, cinnamic aldehyde, cinnamic alcohol, citral, citronellol, coumarin, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, hydroxyisohexyl-3-cyclohexene carbaldehyde, isoeugenol, alpha-isomethyl ionone, limonene, linalool, methyl 2-octynoate, oak moss extract and/or moss extract.
6. The skin care composition of the cedar bud extract suitable for infants is characterized by comprising the following components in parts by mass:
1.5-4.5 parts of hexadecanol;
4-6 parts of caprylic/capric triglyceride;
monoglyceride 0.6-1.3;
lecithin 0.2-0.8;
0.5-1.5 parts of carbomer 940;
0.5 to 1.5 portions of triethanolamine;
1-5 parts of a cedar bud extract;
and the number of the first and second groups, 0.0001 to 0.001 portion of amyl cinnamic aldehyde, 0.0001 to 0.001 portion of amyl cinnamic alcohol, 0.0001 to 0.001 portion of anisyl alcohol, 0.0001 to 0.001 portion of benzyl benzoate, 0.0001 to 0.001 portion of benzyl cinnamate, 0.0001 to 0.001 portion of benzyl salicylate, 0.0001 to 0.001 portion of butylbenzyl methyl propionaldehyde, 0.0001 to 0.001 portion of cinnamic aldehyde, 0.0001 to 0.001 portion of cinnamyl alcohol, 0.0001 to 0.001 portion of citral, 0.0001 to 0.001 portion of citronellol, 0.0001 to 0.001 portion of coumarin, 0.0001 to 0.001 portion of eugenol, 0.0001 to 0.001 portion of farnesol, 0.0001 to 0.001 portion of geraniol, 0.0001 to 0.001 portion of hexyl cinnamic aldehyde, 0.0001 to 0.001 portion of hydroxycitronellaldehyde, 0.001 to 0.001 portion of isoquercus-3-cyclohexenol, 0.001 to 0.001 portion of myrcene ketone extract, 0.001 to 0.001 portion of isoquercus-0.0001 and 0.001 portion of isoquercus-0.001 portion of linalool or 0.0001 to 0.001 portion of quercus methyl quercus-0.001 portion of linalool extract;
deionized water to make up 100 parts.
7. The skin care composition of claim 6, wherein the cedar bud extract is present in an amount of 3% by mass of the composition.
8. <xnotran> 6 , , , , , , , , , , , , , , , , , , , , -3- , , α - , , , 2- , , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% , 1wt% -3- , 1wt% , 1wt% α - , 1wt% , 1wt% , 1wt%2- , 1wt% , 1wt% . </xnotran>
9. An infant skin care product comprising the cedar bud extract skin care composition according to any one of claims 7 to 8.
10. The infant skin care product of claim 9, comprising body lotions, body creams, body oils and body creams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210939145.2A CN115154377A (en) | 2022-08-05 | 2022-08-05 | Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210939145.2A CN115154377A (en) | 2022-08-05 | 2022-08-05 | Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115154377A true CN115154377A (en) | 2022-10-11 |
Family
ID=83479222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210939145.2A Pending CN115154377A (en) | 2022-08-05 | 2022-08-05 | Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115154377A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850274A1 (en) * | 2003-01-27 | 2004-07-30 | Gattefosse Ets Sa | New extracts of Cryptomeria japonica buds, useful e.g. as cytoprotectants for the skin in cosmetic compositions having antiaging and moisturizing action |
| FR2850272A1 (en) * | 2003-01-27 | 2004-07-30 | Gattefosse Ets Sa | New extracts of Cryptomeria japonica buds, are stimulants of extracellular matrix component synthesis by dermal cells and cytoprotectants for the skin, useful in cosmetic compositions |
| CN109528595A (en) * | 2018-12-29 | 2019-03-29 | 广州睿森生物科技有限公司 | A kind of plant composition for skin care and preparation method thereof |
| CN110755339A (en) * | 2018-07-28 | 2020-02-07 | 蒋占琼 | Baby bath lotion |
| CN110787091A (en) * | 2019-12-03 | 2020-02-14 | 株洲千金药业股份有限公司 | Itching-relieving and anti-allergy infant washing and protecting preparation and application thereof |
| CN110801419A (en) * | 2018-08-04 | 2020-02-18 | 蒋永胜 | Infant shampoo and preparation method thereof |
-
2022
- 2022-08-05 CN CN202210939145.2A patent/CN115154377A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850274A1 (en) * | 2003-01-27 | 2004-07-30 | Gattefosse Ets Sa | New extracts of Cryptomeria japonica buds, useful e.g. as cytoprotectants for the skin in cosmetic compositions having antiaging and moisturizing action |
| FR2850272A1 (en) * | 2003-01-27 | 2004-07-30 | Gattefosse Ets Sa | New extracts of Cryptomeria japonica buds, are stimulants of extracellular matrix component synthesis by dermal cells and cytoprotectants for the skin, useful in cosmetic compositions |
| CN110755339A (en) * | 2018-07-28 | 2020-02-07 | 蒋占琼 | Baby bath lotion |
| CN110801419A (en) * | 2018-08-04 | 2020-02-18 | 蒋永胜 | Infant shampoo and preparation method thereof |
| CN109528595A (en) * | 2018-12-29 | 2019-03-29 | 广州睿森生物科技有限公司 | A kind of plant composition for skin care and preparation method thereof |
| CN110787091A (en) * | 2019-12-03 | 2020-02-14 | 株洲千金药业股份有限公司 | Itching-relieving and anti-allergy infant washing and protecting preparation and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《年轻肌肤的密码——GATULINE® RENEW 唤肤修》: "《年轻肌肤的密码——Gatuline® Renew 唤肤修》", pages 79 - 10, Retrieved from the Internet <URL:https://mp.weixin.qq.com/s?src=3×tamp=1688544100&ver=1&signature=3*anYOGdPKnIf0sNZ3HyXEuebmRwNEndH68ZsyzQWiCrfvJNkDu0QMkiAMiCpqESP7IW0koRf6VL8TH1Vgw97G0OkQSojUhFbRddDd9Cr8U2Ol1RVWpRQuAbBvg9ChyDk4kt3ud82KJV8HoYob57HM87f1BymtWiNOdSmRQ8U7s=> * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370605B (en) | Smoothening and moisturizing lotion composition and preparation method thereof | |
| AU2014330911B2 (en) | Composition | |
| KR20140142302A (en) | Cosmetic skin composition with soothing effect and its use | |
| KR20180045539A (en) | Cosmetic composition for treating atopic dermatitis and method thereof | |
| CN108113894A (en) | A kind of infant's activity milky lotion and preparation method thereof | |
| CN112237556A (en) | Oil composition for repairing skin barrier and application thereof | |
| KR101452769B1 (en) | Cosmetic compositions comprising xylitol fatty acid ester with continuous cooling effect | |
| CN109260039A (en) | A kind of moisturizing remediation composition and preparation method thereof | |
| CN116350550A (en) | Face cream with moisturizing and soothing effects and preparation method thereof | |
| CN115154377A (en) | Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition | |
| CN113143797A (en) | Moisturizing lotion containing composition for improving atomization effect and preparation method thereof | |
| US20190343746A1 (en) | Cosmetic composition including gamma-pga as active ingredient | |
| CN107955756A (en) | A kind of handmade soap and preparation method thereof | |
| WO2021170380A1 (en) | Improved preparation | |
| CN103211740B (en) | Moisturizing emulsion composition containing guava extractive and hydrolyzed pearl | |
| CN117598932B (en) | Sun-screening synergistic composition, water-in-oil type high-power sun-screening composition and preparation method thereof | |
| KR102670637B1 (en) | Waxing composition for hair removal and preparation thereof | |
| CN116327620B (en) | Calendula skin care oil for infants and preparation method thereof | |
| KR102723936B1 (en) | Skin external composition comprising badger oil | |
| EP2976059A1 (en) | Agent for the temporary shaping of keratin-containing fibres | |
| ITTO20070815A1 (en) | USE OF ALCHILOSSAZOLIDINONE AS A MOISTURIZING COSMETIC AGENT AND SKIN HYDRATION PROCEDURE | |
| RU2500383C1 (en) | Sun-protection cream | |
| RU2635524C1 (en) | Cosmetic cream | |
| KR101957351B1 (en) | Natural cosmetic composition using aronia | |
| EP3454830B1 (en) | Oil-in-water emulsions with isoflavone containing plant extracts and mica pigments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221011 |